Menu

Zhengye Biotechnology Holding Limited ZYBT

Full chart Compare
Set alert

Price alert · ZYBT

All alert types
1.53 USD +0.03 (+2.00%)

Nov 9, 2026, 2:14 PM EST

1.42 Day range 1.56
0.616 52-week range 8.01
YTD
+33.04%
1 year
-25.37%

Revenue & Expenses

Other Income → Expenses: $13.78MExpenses → Selling, General & Admin: $74.92MExpenses → Research & Development: $18.01MExpenses → Interest Expense: $3.40MExpenses → Income Tax: $11.10MGross Profit → Expenses: $23.87MRevenue → Gross Profit: $23.87MRevenue → Cost of Revenue: $92.49MNet Loss → Expenses: $69.78MOther Income$13.78MGross Profit$23.87MNet Loss$69.78MCost of Revenue$92.49MExpenses$107.43MSelling, General & Admin$74.92MResearch & Development$18.01MInterest Expense$3.40MIncome Tax$11.10MRevenue$116.36M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ZYBT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
116.36M186.36M211.65M260.27M
23.87M91.30M117.51M147.88M
-69.07M14.66M41.27M65.83M
-69.78M11.31M31.46M46.73M
-1.470.250.691.02
ZYBT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
50.33M18.61M27.19M9.75M
436.47M493.25M499.89M519.67M
129.76M140.71M160.62M162.81M
75.08M86.43M89.85M64.88M
249.85M283.96M272.85M296.50M
ZYBT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
13.33M41.05M48.18M17.34M
-12.63M-27.66M-11.77M-27.33M
32.31M-22.13M-18.98M13.46M
-1.01M-13.48M-6.34M-27.33M
31.73M-8.58M17.44M3.46M